The announcement comes less than a month after the device maker said that European regulators had given the nod to the same device — the Ellipse ICD.
The Ellipse is the industry’s smallest high-voltage ICD, said a companynews releasethat described the product as the result of physician input. The device design was arrived at through focus groups of physicians who translated their vision in clay.
“We feel collaboration with physicians in regards to the planning and design of our devices is imperative in order to develop truly breakthrough technologies,” said Dr. Eric S. Fain, president of theSt. Jude Medical Cardiac Rhythm Management Division, in a statement.
On Tuesday, St. Jude Medical announced that it had won FDA approval on its Assura line of ICDs and CRT-Ds.
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.